Structure Therapeutics Inc. (GPCR)
GPCR trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$22.31
-6.69% on the day
Market cap
$1.6B
Small cap
Revenue
Not reported in SEC XBRL data
Net income
Not reported in SEC XBRL data
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | GPCR on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2023 |
| SEC CIK | 0001888886 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | E9 |
Financials
Not reported in SEC XBRL data.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2026-05-07 |
| Latest annual report | 10-K | 2026-02-26 |
| Latest quarterly / interim | 10-Q | 2026-08-06 |
| Latest current report FORM 8-K | 8-K | 2026-09-08 |
| Latest proxy | DEF 14A | 2026-04-23 |
Source: SEC EDGAR submissions feed, 270 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -18.1% |
| 1 month | -43.9% |
| 3 months | -52.5% |
| Year to date | -68.6% |
| 1 year | -27.6% |
| From 52-week high | -76.7% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| OCUL | Ocular Therapeutix Inc. | $7.24 | -4.23% | $1.6B |
| GENB | Generate Biomedicines Inc. | $12.26 | -11.45% | $1.6B |
| ANIP | ANI Pharmaceuticals Inc. | $70.84 | -3.74% | $1.6B |
| ZBIO | Zenas BioPharma Inc. | $25.16 | -4.70% | $1.6B |
| CMPS | COMPASS Pathways Plc American Depository Shares | $11.14 | -3.38% | $1.5B |
| NUVB | Nuvation Bio Inc. | $4.72 | -3.67% | $1.7B |
| ETON | Eton Pharmaceuticals Inc. | $53.33 | -3.48% | $1.5B |
| INVA | Innoviva Inc. | $20.74 | -3.31% | $1.5B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier